期刊文献+

三种孕激素对体外培养子宫肌瘤细胞生长的影响 被引量:3

下载PDF
导出
摘要 目的:观察不同浓度孕酮、左炔诺孕酮和醋酸甲羟孕酮对体外培养子宫肌瘤细胞生长的影响。方法:体外培养子宫肌瘤细胞,采用四甲基偶氮唑蓝(MTT)法检测应用不同浓度孕酮、左炔诺孕酮和醋酸甲羟孕酮后子宫肌瘤细胞增殖的情况,并采用细胞免疫化学方法检测增殖细胞核抗原(PCNA)的表达。结果:成功进行子宫肌瘤细胞的原代培养,加入浓度为10、1000ng/mL孕酮、左炔诺孕酮和醋酸甲羟孕酮后,与对照组相比,明显促进细胞增殖,差异有显著性(P<0.05),并且呈剂量依赖性,浓度为0.1ng/mL时轻度促进细胞增殖,与对照组相比差异无显著性(P>0.05)。加入浓度为1000ng/mL孕酮、左炔诺孕酮和醋酸甲羟孕酮后,与对照组相比,明显促进胞核内PCNA的表达(P<0.05)。结论:孕酮、左炔诺孕酮和醋酸甲羟孕酮可刺激体外培养肌瘤细胞增殖,呈剂量依赖性。
出处 《实用医学杂志》 CAS 2008年第22期3819-3821,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献8

  • 1Venkatachalam S, Bagratee J S, Moodey J. Medical management of uterine fibroids with medroxyprogesterone acetate (Depo provera): a pilot study [J]. Obstet Gynaecol,2004, 24(7): 798-800.
  • 2Grigoriev V, Chen-Mok M, Tarasova M, et al. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas [ J ]. Fertil Steril, 2003, 79 (5) : 1194 - 1198.
  • 3曹爽,薛晓鸥.子宫肌瘤细胞培养方法之比较[J].锦州医学院学报,2004,25(3):16-18. 被引量:3
  • 4Luukkainen T, Lhteemki P, Toivonen J. Levonorgestrel-releasing intrauterine device [J]. Ann Med, 1990,22 (2) : 85-90.
  • 5Xiao B L, Zhu P D, Wu S C, et al. Effect of levonorgestrel- releasing intrauterine device on hormonal profile and menstrual pattern after long-term use [ J ]. Contraception, 1995,51 (6) : 359- 365.
  • 6孙丹利,蒋海瑛,方素华,楼红英.哺乳妇女单次注射迪波盖司通~长效避孕针后血清和乳液中MPA浓度变化[J].生殖与避孕,2005,25(8):474-477. 被引量:1
  • 7黄杰雄.增殖细胞核抗原的研究进展[J].国外医学(生理病理科学与临床分册),1994,14(1):9-11. 被引量:94
  • 8Yamada T, Nakago S, Kurachi O, et al. Progesterone downregulates insulin-like growth factor- I expression in cultured human uterine leiomyoma cells [ J ]. Human Reproduction, 2004,19 (4) : 815-821.

二级参考文献16

  • 1Arici A, Sozen I. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma [J]. Am J Obstet Gynecol, 2003, 188(1): 76-83.
  • 2Kobayashi Y, Nikaido T, Zhai YL, et al. Leuprolide acetate-treated leiomyomas retain their relative overexpression of collagen type I and collagen type III messenger ribonucleic acid [J]. J Soc Gynecol Investig, 1998, 5(1): 44-47.
  • 3Carney SA, Tahara H, Swartz CD,et al. Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics[J]. Lab Invest, 2002, 82(6): 719-728.
  • 4Strawn EY Jr, Novy MJ, Burry KA, et al. Insulin-like growth factor I promotes leiomyoma cell growth in vitro [J]. Am J Obstet Gynecol,1995, 172(6): 1837-1843.
  • 5Cheng YM, Chou CY, Huang SC, et al. Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists [J]. BJOG, 2001, 108(1): 95-102.
  • 6Sun DL, Shao QX & Sang GW. A multicentered clinical trial of the long-acting injectable contraceptive Depo Provera in Chinese women. Contraception, 2000, 62(1): 15-8.
  • 7Saxena BN, Shrimanker K & Grudzinskas JG. Levels of contraceptive steroids in breast milk and plasma of lactating women. Contraception, 1977, 16(6):605-13.
  • 8Tieng P, Chalong Y & Ronald. The long-term growth and development of children exposed to Depo-provera during pregnancy or lactation. Contraception, 1992, 45(4):313-24.
  • 9Koetsawang S. Injected long-acting medroxyprogesterone acetate: effect on human lactation and concentration in milk.Journal of the Medical Association of Thailand, 1977, 60(2):57-60.
  • 10Koetsawang S, Nukularn P & Fotherby K. Transfer of contraceptive steroids in milk of women using long-acting gestagens. Contraception, 1982, 25(4):321-31.

共引文献95

同被引文献67

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部